| Patent | Date |
|---|
Methods Of Identifying Responses To Map Kinase Inhibition Therapy
App 20220136057 - Johannessen; Cory M. ; et al. | 2022-05-05 |
Methods Of Diagnosing And Treating Cancer In Patients Having Or Developing Resistance To A First Cancer Therapy
App 20210404014 - Garraway; Levi A. ; et al. | 2021-12-30 |
C-RAF Mutants that Confer Resistance to RAF Inhibitors
App 20210388325 - Emery; Caroline ; et al. | 2021-12-16 |
ERK1 and ERK2 mutations that confer resistance to MAPK pathway inhibitors
Grant 11,186,874 - Goetz , et al. November 30, 2 | 2021-11-30 |
Methods Of Identifying Responses To Map Kinase Inhibition Therapy
App 20210277482 - Johannessen; Cory M. ; et al. | 2021-09-09 |
Methods of diagnosing and treating cancer in patients having or developing resistance to a first cancer therapy
Grant 11,078,540 - Garraway , et al. August 3, 2 | 2021-08-03 |
Methods of identifying responses to map kinase inhibition therapy
Grant 10,968,484 - Johannessen , et al. April 6, 2 | 2021-04-06 |
MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors
App 20210008147 - Garraway; Levi A. ; et al. | 2021-01-14 |
MEK1 mutation conferring resistance to RAF and MEK inhibitors
Grant 10,788,496 - Garraway , et al. September 29, 2 | 2020-09-29 |
C-RAF Mutants that Confer Resistance to RAF Inhibitors
App 20190142830 - Emery; Caroline ; et al. | 2019-05-16 |
Selective Treatment Of Prmt5 Dependent Cancer
App 20180271891 - Garraway; Levi A. ; et al. | 2018-09-27 |
A MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors
App 20180217147 - Garraway; Levi A. ; et al. | 2018-08-02 |
Tumor And Microenvironment Gene Expression, Compositions Of Matter And Methods Of Use Thereof
App 20180100201 - Garraway; Levi A. ; et al. | 2018-04-12 |
MEK1 mutation conferring resistance to RAF and MEK inhibitors
Grant 9,880,169 - Garraway , et al. January 30, 2 | 2018-01-30 |
ERK1 and ERK2 Mutations That Confer Resistance to MAPK Pathway Inhibitors
App 20170268065 - Goetz; Eva M. ; et al. | 2017-09-21 |
Methods of Diagnosing and Treating Cancer in Patients Having or Developing Resistance to a First Cancer Therapy
App 20170268069 - Garraway; Levi A. ; et al. | 2017-09-21 |
C-RAF Mutants that Confer Resistance to RAF Inhibitors
App 20170204383 - Emery; Caroline ; et al. | 2017-07-20 |
C-RAF mutants that confer resistance to RAF inhibitors
Grant 9,629,839 - Emery , et al. April 25, 2 | 2017-04-25 |
MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors
App 20160216266 - GARRAWAY; LEVI A. ; et al. | 2016-07-28 |
Compositions and methods of treating head and neck cancer
Grant 9,370,551 - Cong , et al. June 21, 2 | 2016-06-21 |
Methods Of Identifying Responses To Map Kinase Inhibition Therapy
App 20160024589 - Johannessen; Cory M. ; et al. | 2016-01-28 |
MEK Mutations Conferring Resistance to MEK Inhibitors
App 20150346204 - Garraway; Levi A. ; et al. | 2015-12-03 |
MEK mutations conferring resistance to MEK inhibitors
Grant 9,084,781 - Garraway , et al. July 21, 2 | 2015-07-21 |
Diagnostic And Treatment Methods In Patients Having Or At Risk Of Developing Resistance To Cancer Therapy
App 20150141470 - Garraway; Levi A. ; et al. | 2015-05-21 |
C-raf Mutants That Confer Resistance To Raf Inhibitors
App 20150133478 - Emery; Caroline ; et al. | 2015-05-14 |
Compositions And Methods Of Treating Head And Neck Cancer
App 20130171124 - Cong; Le ; et al. | 2013-07-04 |
MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors
App 20130143911 - Garraway; Levi A. ; et al. | 2013-06-06 |
Methods of Diagnosing and Treating Cancer in Patients Having or Developing Resistance to a First Cancer Therapy
App 20130059851 - Garraway; Levi A. ; et al. | 2013-03-07 |
Mek Mutations Conferring Resistance To Mek Inhibitors
App 20120015973 - Garraway; Levi A. ; et al. | 2012-01-19 |
Methods for identifying and using SNP panels
Grant 7,981,609 - Rubin , et al. July 19, 2 | 2011-07-19 |
Methods for identifying and using SNP panels
App 20090004652 - Rubin; Mark A. ; et al. | 2009-01-01 |
| 